El Maghraby G M, Williams A C, Barry B W
Drug Delivery Group, Postgraduate Studies in Pharmaceutical Technology, The School of Pharmacy, University of Bradford, UK.
J Pharm Pharmacol. 1999 Oct;51(10):1123-34. doi: 10.1211/0022357991776813.
Deformable vesicles and traditional liposomes were compared as delivery systems for oestradiol to elucidate possible mechanisms of drug delivery through human skin. Accordingly, epidermal permeation of oestradiol from optimized deformable vesicles and traditional liposome formulations was studied under low dose non-occluded conditions. Five mechanisms were investigated. A free drug mechanism compared low-dose permeation through skin with drug release determined after separation of the free drug. Penetration enhancement was researched by studying skin pretreatment with empty vesicles. Improved drug uptake by skin was monitored by dipping stratum corneum into different formulations for 10 min and determining drug uptake. The possibility that intact vesicles permeate through the epidermis was tested by comparing permeation from 136-nm vesicles with that from >500-nm vesicles, assuming that penetration depends on vesicle size. The possibility that different entrapment efficiencies in alternative formulations could be responsible for the difference in delivery was also evaluated. Lipid vesicles improved the skin delivery of oestradiol compared with delivery from an aqueous control. Maximum flux (Jmax) was increased 14- to 17-fold by use of deformable vesicles and 8.2- to 9.8-fold by use of traditional liposomes. Deformable vesicles were thus superior to traditional liposomes. Drug release was negligible over the period during which skin flux was maximum. Pretreatment with empty vesicles resulted in an enhancement ratio of 4.3 for pure phosphatidylcholine (PC) vesicles but the enhancement ratio ranged from only 0.8 to 2.4 for other formulations. Vesicles increased drug uptake into the stratum corneum 23- to 29-fold. Relative flux values obtained from small and large vesicles were similar. No correlation was found between entrapment efficiency and skin delivery. The results showed no evidence of a free drug mechanism, but revealed a possible penetration-enhancing effect for pure PC vesicles, although this was not the only mechanism operating. The positive uptake suggested that lipid vesicles increased drug partitioning into the skin. The data provided no evidence for in-vitro liposome penetration through skin as distinct from vesicle penetration into the stratum corneum.
将可变形囊泡和传统脂质体作为雌二醇的递送系统进行比较,以阐明药物透过人体皮肤的可能机制。因此,在低剂量非封闭条件下,研究了优化后的可变形囊泡和传统脂质体制剂中雌二醇的表皮渗透情况。研究了五种机制。一种游离药物机制是将低剂量药物透过皮肤的渗透情况与游离药物分离后测定的药物释放情况进行比较。通过研究用空囊泡预处理皮肤来探究渗透增强作用。将角质层浸入不同制剂中10分钟并测定药物摄取量,以此监测皮肤对药物摄取的改善情况。通过比较136纳米囊泡和大于500纳米囊泡的渗透情况来测试完整囊泡透过表皮的可能性,假定渗透取决于囊泡大小。还评估了不同制剂中不同包封效率是否可能是递送差异的原因。与水性对照相比,脂质囊泡改善了雌二醇的皮肤递送。使用可变形囊泡时最大通量(Jmax)增加了14至17倍,使用传统脂质体时增加了8.2至9.8倍。因此,可变形囊泡优于传统脂质体。在皮肤通量最大的时间段内,药物释放可忽略不计。用空囊泡预处理后,纯磷脂酰胆碱(PC)囊泡的增强比为4.3,但其他制剂的增强比仅在0.8至2.4之间。囊泡使角质层对药物的摄取增加了23至29倍。从大小不同的囊泡获得的相对通量值相似。未发现包封效率与皮肤递送之间存在相关性。结果没有显示游离药物机制的证据,但揭示了纯PC囊泡可能具有渗透增强作用,尽管这不是唯一起作用的机制。阳性摄取表明脂质囊泡增加了药物在皮肤中的分配。数据没有提供体外脂质体穿透皮肤的证据,与囊泡穿透角质层不同。